Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 932.00K | 959.00K | 1.30M | 1.41M | 1.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54M | 2.32M | 2.92M | 3.07M | 3.47M |
| Operating Income | -2.54M | -2.32M | -2.92M | -3.07M | -3.47M |
| Income Before Tax | -2.45M | -2.29M | -2.85M | -3.00M | -3.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.45M | -2.29M | -2.85M | -3.00M | -3.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.45M | -2.29M | -2.85M | -3.00M | -3.47M |
| EBIT | -2.54M | -2.32M | -2.92M | -3.07M | -3.47M |
| EBITDA | -2.52M | -2.30M | -2.89M | -3.04M | -3.45M |
| EPS Basic | -0.21 | -0.25 | -0.36 | -0.39 | -0.49 |
| Normalized Basic EPS | -0.13 | -0.16 | -0.22 | -0.24 | -0.30 |
| EPS Diluted | -0.21 | -0.25 | -0.36 | -0.39 | -0.49 |
| Normalized Diluted EPS | -0.13 | -0.16 | -0.22 | -0.24 | -0.30 |
| Average Basic Shares Outstanding | 11.71M | 9.20M | 8.01M | 7.72M | 7.11M |
| Average Diluted Shares Outstanding | 11.71M | 9.20M | 8.01M | 7.72M | 7.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |